Navigation Links
Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
Date:1/3/2008

UPPSALA, Sweden, January 3 /PRNewswire/ -- Amic AB (Uppsala, Sweden) announced today that is has been granted a non-exclusive license under patent rights of Roche Diagnostics to commercialise a point-of-care (POC) test for NT-proBNP on the European market.

NT-proBNP is a key cardiac marker for a broad array of cardiovascular conditions, including the diagnosis and management of heart failure, and risk stratification of patients with acute coronary syndrome.

"This agreement with Roche Diagnostics marks a major milestone in Amic's development. The NT-proBNP test will be one of the first to be launched on our Forecast POC diagnostic system. The market for NT-proBNP testing is growing significantly in Europe, and we see great potential in the future for monitoring and managing the treatment of heart failure patients at the point of care," says Lars Gunneflo, CEO, Amic AB.

About Amic AB

Amic is a privately held POC diagnostic company with R&D and manufacture facilities based in Uppsala, Sweden. The company is developing the next generation of POC diagnostic tests using its proprietary microfluidic technology. The technology uses a moulded plastic device called the 4castchip(R), and a state-of-the-art optical detection system for precise and sensitive quantification of immunoassays.

The Company intends to launch the Forecast POC Diagnostic System with high-performance test kits for the cardiac markers NT-proBNP and cTnI.

The marker specific test cartridge contains the 4castchip(R) in a user friendly format for rapid analysis of whole-blood patient samples at the point of care. The Forecast Reader is a low-cost analyser designed for fail-safe operation in hospital and primary care settings with full connectivity to laboratory informations systems.

For more information please visit the company website at http://www.amic.se


'/>"/>
SOURCE Amic AB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... This June ... Tampa, Florida. As an exclusive sales and service provider of the ALPINION line, ... 2016 is the premier conference for healthcare technology management. The event draws more than ...
(Date:5/5/2016)... ... May 05, 2016 , ... ProMIS Neurosciences ... its first three targets, it has identified a fourth in a series of ... the development and progression of Alzheimer’s disease (AD). , “This discovery ...
(Date:5/4/2016)... , May 4, 2016  Bayer today announced ... compound Stivarga ® (regorafenib) tablets for the ... has met its primary endpoint of a statistically ... RESORCE, evaluated the efficacy and safety of regorafenib ... after treatment with sorafenib. The safety and tolerability ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... growth, has leveraged recent innovations in biotechnology to help treat hormonal and stress ... hair loss, Nutrafol® has captured the hearts of key opinion leaders in the ...
Breaking Biology Technology:
(Date:3/8/2016)... 2016   Valencell , the leading innovator ... has secured $11M in Series D financing. The ... venture fund being launched by UAE-based financial services ... investors TDF Ventures and WSJ Joshua Fund. Valencell ... triple-digit growth and accelerate its pioneering innovation in ...
(Date:3/3/2016)... , March 3, 2016  2016FLEX, organized by ... week highlighting advancements in flexible, hybrid and printed ... setting attendance - have gathered for short courses, ... field of electronics. The Flex Conference celebrates its ... for companies, R&D organizations, and universities contributing to ...
(Date:3/2/2016)... March 2, 2016 ... addition of the  "Global Biometrics Market in ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global biometrics ... at a CAGR of around 27%   ... has announced the addition of the  "Global ...
Breaking Biology News(10 mins):